{
    "clinical_study": {
        "@rank": "95865", 
        "acronym": "Se-AOX", 
        "arm_group": [
            {
                "arm_group_label": "Se-OI>  200", 
                "description": "patients  who  received  form  of  sodium  selenite  pentahydrate  at  750 mg/day  for  6  days  immediately  after  admission  to  our  department  (1000  mg  of  sodium selenite pentahydrate = 333 micrograms of selenium) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction  of  inspired  oxygen) was higher than 200"
            }, 
            {
                "arm_group_label": "Se-OI  <200", 
                "description": "patients  who  received  form  of  sodium  selenite  pentahydrate  at  750 mg/day  for  6  days  immediately  after  admission  to  our  department  (1000  mg  of  sodium selenite pentahydrate = 333 micrograms of selenium) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction  of  inspired  oxygen) was lower than 200"
            }, 
            {
                "arm_group_label": "Placebo-OI> 200", 
                "description": "patients who received continuous saline NaCl 50 ml/day for  6  days  as  a  continuous  infusion  (excluding  additional  infusion  therapy) and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction  of  inspired  oxygen) was higher than 200"
            }, 
            {
                "arm_group_label": "Placebo-OI  <200", 
                "description": "patients  who who received continuous saline NaCl 50 ml/day for  6  days  as  a  continuous  infusion  (excluding  additional  infusion  therapy)  and oxygenation index (OI) by PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction  of  inspired  oxygen) was lower than 200"
            }
        ], 
        "brief_summary": {
            "textblock": "This  study looked  at  parenteral  administration  of  selenium  to  septic  patients  and\n      subsequently  monitored  dynamic changes of selected activities of antioxidant enzymes and\n      the development of clinical status."
        }, 
        "brief_title": "Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Severe Sepsis", 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients will be divided  into  two  groups.  Se-group  who  received  selenium\n      supplementation  during  hospitalization  in  the  form  of  sodium  selenite  pentahydrate\n      at  750 mg/day  for  6  days  immediately  after  admission  to  our  department  (1000  mg\n      of  sodium selenite pentahydrate = 333 micrograms of selenium) (Selenase, Vivax; selenium\n      hereinafter).\n\n      The placebo group will receive continuous saline NaCl 50 ml/day for  6  days  as  a\n      continuous  infusion  (excluding  additional  infusion  therapy).  Patients  will befurther\n      divided  into  subgroups  according  to  OI  on  the  day  of  admission  to  ICU. The\n      oxygenation index (OI) PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction\n      of  inspired  oxygen)  ratio  in  patients  will be  calculated daily.\n\n      The  determination  of  biochemical  and  hematological  parameters  of  blood  samples\n      will be as a part of the routine diagnostic methods. Data collection for the Se-AOX study\n      will be performed at  two-day  intervals:  T1  (1st-2nd  day),  T2  (3rd-4th  day)  and  T3\n      (5th-6th  day).  Kinetic methods  for  estimating  the  activities  of  glutathione\n      peroxidase  (GPx,  E.C.  1.11.1.9), glutathione   reductase   (GR,   E.C.1.6.4.2)   will be\n      performed   using   a   kit   (Sigma-Aldrich, Germany) and that of superoxide dismutase\n      (SOD, E.C. 1.15.1.1) by means of the SOD-Assay Kit-WST (Fluka, Japan) following the user\n      manual provided."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  sepsis, severe sepsis or septic shock, APACHE II score between 19 and 24 points after\n             admision\n\n        Exclusion Criteria:\n\n          -  mechanical  ventilation  for  less  than  24h, neuromuscular  disease  and  terminal\n             illness  were  also  excluding  criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Critically ill patients with APACHE II score between 19 and 24 points after admision with\n        sepsis, severe sepsis or septic shock during hospitalization as defined by the\n        International Sepsis Definitions Conference"
            }
        }, 
        "enrollment": {
            "#text": "4", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026856", 
            "org_study_id": "Se-AOX 109/2011"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Se-OI>  200", 
                    "Se-OI  <200"
                ], 
                "intervention_name": "sodium  selenite  pentahydrate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Placebo-OI> 200", 
                    "Placebo-OI  <200"
                ], 
                "intervention_name": "placebo - continuous saline NaCl 50 ml", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "oxidative stress, sepsis, selenium", 
        "lastchanged_date": "December 31, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ko\u0161ice", 
                    "country": "Slovakia", 
                    "zip": "041 90"
                }, 
                "name": "1st clinic of anesthesiology and intesive care, University hospital of Louis Pasteur"
            }
        }, 
        "location_countries": {
            "country": "Slovakia"
        }, 
        "number_of_groups": "4", 
        "official_title": "Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis", 
        "other_outcome": {
            "measure": "antioxidant enzymes", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Slovak Republic: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "mortality", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "reference": {
            "PMID": "23387814", 
            "citation": "Ko\u010dan L, Va\u0161kov\u00e1 J, Va\u0161ko L, Lakyov\u00e1 L, Ko\u010danov\u00e1 H, Simonov\u00e1 J, Simon R, Firment J. [Acute multiple organ failure after endoscopic polypectomy]. Cas Lek Cesk. 2012;151(12):568-72. Slovak."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026856"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Pavol Jozef Safarik University", 
            "investigator_full_name": "Ko\u010dan Ladislav", 
            "investigator_title": "MD PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "21121149", 
            "citation": "Kocan L, Firment J, Simonov\u00e1 J, Vaskov\u00e1 J, Guzy J. [Selenium supplementation in patients with severe acute pancreatitis]. Rozhl Chir. 2010 Aug;89(8):518-21. Slovak."
        }, 
        "secondary_outcome": {
            "description": "PaO2/FiO2 (partial pressure of oxygen in arterial blood/  fraction  of  inspired  oxygen)", 
            "measure": "The oxygenation index", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Pavol Jozef Safarik University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pavol Jozef Safarik University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}